StockNews.com started coverage on shares of Veradigm (NASDAQ:MDRX – Free Report) in a research report sent to investors on Saturday morning. The firm issued a hold rating on the software maker’s stock.
Separately, Stephens raised their price target on Veradigm from $7.00 to $13.00 and gave the stock an “equal weight” rating in a research note on Friday, January 31st.
Get Our Latest Stock Report on Veradigm
Veradigm Price Performance
Veradigm Company Profile
Veradigm Inc, a healthcare technology company, provides information technology solutions and services to healthcare organizations in the United States, Canada, and internationally. It offers electronic health records (EHR), information connectivity, private cloud hosting, outsourcing, analytics, patient access, and population health management solutions.
Further Reading
- Five stocks we like better than Veradigm
- Insider Buying Explained: What Investors Need to Know
- Bearish Investors Can Seek Refuge in Recession-Resistant ETFs
- How the NYSE and NASDAQ are Different, Why That Matters to Investors
- 3 Oversold Magnificent Seven Stocks at Key Levels: Buy Now?
- 10 Best Airline Stocks to Buy
- 3M to Hit $175 by Mid-Year, and Higher Highs Are Likely
Receive News & Ratings for Veradigm Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Veradigm and related companies with MarketBeat.com's FREE daily email newsletter.
